GPCR Bathi resik saben saham sajrone 12 wulan pungkasan structuretx.com

Structure Therapeutics relies on transparent management and a strong R&D base within the GLP-1 segment. The rolling annual earnings per share snapshot on GURU.Markets contains data where the value of -3.06 serves as the current metric, confirming the company's status as an ambitious innovator in the fight against obesity. High patent barriers and strict FDA requirements protect the company's technological advantage, shutting out smaller players.

GPCR (Structure Corp) riwayat Bathi resik saben saham (EPS TTM) saka 28.04.2023 nganti 10.11.2026

Rincian analitis lan laporan data perusahaan Structure Therapeutics Inc (GPCR)

- rega saham lan target rega konsensus:

Rega saham Structure Therapeutics|GPCR - Rata-rata rega prakiraan

- data kapitalisasi pasar:

Biji pasar Structure Therapeutics Inc.|GPCR - Total Nilai Bisnis

- indikator nilai aset resik miturut neraca:

Nilai Buku saben Saham Structure Therapeutics|GPCR - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku structuretx.com|GPCR - Aset Agregat Perusahaan

- rincian struktur utang lan likuiditas bisnis:

Utang marang Ekuitas Structure Therapeutics|GPCR - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Structure Pharma|GPCR - Utang perusahaan|Utang-utang marang kapitalisasi buku Structure Therapeutics Inc.|GPCR - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Structure Therapeutics|Likuiditas cepet structuretx.com

- indikator pendapatan resik lan kelipatan nilai:

GPCR - Penghasilan resik|Bathi sing dikarepake Structure Therapeutics|GPCR - Periode bali modal bisnis|Prakiraan rega marang bathi Structure Therapeutics Inc.|GPCR - Rasio nilai perusahaan marang wutah bathi|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Structure Therapeutics Inc.|GPCR - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Structure Therapeutics|GPCR - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan structuretx.com|GPCR - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Structure Therapeutics

Pambiji fundamental perusahaan:Structure Therapeutics (GPCR)

This indicator calculates the aggregate net income over four quarters distributed per common share, allowing for an assessment of real profit generation efficiency regardless of the issuance volume. The negative trend in the 12-month net income per share chart is expected for Structure Therapeutics (GPCR), as colossal development costs for oral GLP-1 agonists temporarily outweigh current revenues.

Pesaing Structure Therapeutics